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Purpose:  Periodontal ligament (PDL) cell differentiation into osteoblasts is important in bone formation. Bone formation is a 
complex biological process and involves several tightly regulated gene expression patterns of bone-related proteins. The ex-
pression patterns of bone related proteins are regulated in a temporal manner both in vivo and in vitro. The aim of this study 
was to observe the gene expression profile in PDL cell proliferation, differentiation, and mineralization in vitro.
Methods:  PDL cells were grown until confluence, which were then designated as day 0, and nodule formation was induced 
by the addition of 50 µg/mL ascorbic acid, 10 mM β-glycerophosphate, and 100 nM dexamethasone to the medium. The dishes 
were stained with Alizarin Red S on days 1, 7, 14, and 21. Real-time polymerase chain reaction was performed for the detection 
of various genes on days 0, 1, 7, 14, and 21. 
Results:  On day 0 with a confluent monolayer, in the active proliferative stage, c-myc gene expression was observed at its 
maximal level. On day 7 with a multilayer, alkaline phosphatase, bone morphogenetic protein (BMP)-2, and BMP-4 gene ex-
pression had increased and this was followed by maximal expression of osteocalcin on day 14 with the initiation of nodule 
mineralization. In relationship to apoptosis, c-fos gene expression peaked on day 21 and was characterized by the post-miner-
alization stage. Here, various genes were regulated in a temporal manner during PDL fibroblast proliferation, extracellular 
matrix maturation, and mineralization. The gene expression pattern was similar. 
Conclusions: We can speculate that the gene expression pattern occurs during PDL cell proliferation, differentiation, and min-
eralization. On the basis of these results, it might be possible to understand the various factors that influence PDL cell prolifera-
tion, extracellular matrix maturation, and mineralization with regard to gene expression patterns.
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INTRODUCTION
Periodontal tissue is composed of epithelial tissue and soft 
and hard connective tissue. Periodontal tissue damage have 
various reasons, most commonly periodontitis, which is de-
structive to the connective tissue matrix and its cells, and re-
sults in periodontal ligament loss, alveolar bone resorption, 
and tooth loss. The major challenges in contemporary peri-
odontal therapy are to re-establish soft tissue attachment to 
the newly formed cementum on the root surface and to re-
store lost bone. This requires regeneration of the gingival 
connective tissue destroyed by inflammation, the formation 
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of new cementum and restoration of bone loss, and most 
importantly, the new attachment of connective tissue fibers 
to the previously diseased root surfaces. Therefore, it is es-
sential for the differentiation of cells responsible for the ce-
mentum, alveolar bone, and fiber production. The periodon-
tal ligament (PDL) is a connective tissue located between the 
cementum and the alveolar bone. It has been confirmed that 
undifferentiated mesenchymal cells in the PDL are essential 
for osteogenesis and cementogenesis in periodontal tissues 
and can differentiate into osteoblasts or cementoblasts [1,2].
PDL cell differentiation into osteoblasts is important in bone 
formation. There is some suggestion that PDL cells can dif-
ferentiate into osteoblasts or cementoblasts, and they are 
implicated in the regeneration of the alveolar bone, cemen-
tum, and PDL [3,4]. Many studies have reported mineralized 
nodule formation by the PDL cells both in vitro and in vivo 
[5,6]. Nodules were formed in rat PDL cell cultures, and when 
10 mM Na-beta-glycerophosphate was added, these nodules 
became mineralized. This suggests that the PDL contains os-
teoprogenitor cells, which differentiate into osteoblasts and 
produce bone-like tissue [6]. In another study, the mineral-
ized nodules were formed on day 21 in 100 nM or 5 µM dexa-
methasone treated human PDL (hPDL) cell groups in a dose-
dependent manner [7]. 
Bone formation is a complex biological process and involves 
several tightly regulated gene expression patterns of bone-
related proteins [8]. The expression of bone-related proteins 
during bone formation has been studied in both in vivo and 
in vitro systems. The expression patterns of bone related pro-
teins in in vivo and in vitro systems are regulated in a tempo-
ral manner. Stein and Lian [8] demonstrated that the expres-
sion of cell cycle or growth-related genes (histone, c-fos, c-myc) 
and extracellular matrix genes (type I collagen [COL I], fibro-
nectin, and transforming growth factor-β1) increased and 
was followed by mineralization-related genes such as osteo-
calcin (OC), osteopontin (OPN), and bone sialoprotein (BSP) 
during bone formation. Therefore, it is reasonable to specu-
late that there are common expression patterns of bone-relat-
ed proteins for osteoblast differentiation. However, it is as-
sumed that each osteoblast culture system has its own spe-
cific expression patterns of bone-related proteins during os-
teoblast differentiation [9]. PDL cells also have their own spe-
cific expression patterns of bone-related proteins during dif-
ferentiation.
Accordingly, Zhumabayeva et al. [10] reported gene expres-
sion patterns (SPARC, Col I, alkaline phosphate [ALP], OPN, 
BSP, OC) in relation to the bone morphogenetic proteins 
(BMP)-7 and dexamethasone. Meanwhile, Strayhorn et al. [11] 
reported the effects of various growth factors (BMPs, platelet-
derived growth factor, and insulin-like growth factor) on os-
teoblast differentiation-associated genes (OPN, OC, BSP, 
Osf2/Cbfa1) in vitro using mouse osteoprogenitor cells. BMPs 
promote regeneration of the bone and also periodontal tis-
sues including alveolar bone, cementum, and PDL [12-14].
However, most of the studies reporting gene expression 
patterns regarding PDL cell differentiation have the limita-
tion that reported genes are only observed at the restricted 
stage during mineralization and studied with regard to vari-
ous growth factors. Hence, the overall gene expression pat-
tern of PDL cells during cell proliferation, bone matrix forma-
tion, maturation, and mineralization needs to be elucidated. 
Therefore, in the present study, we observed the growth-
related (c-myc and c-fos) and differentiation-related [ALP, 
BMP-2, BMP-4 and OC] gene expression patterns during os-
teogenic differentiation of hPDL cells in vitro. 
MATERIALS AND METHODS
Cell isolation and culture 
The PDL tissues were obtained from the PDL of premolar 
teeth extracted for orthodontic reasons. Premolars were col-
lected from donors, at Department of Periodontology, Kyung-
pook National University Hospital. The protocols for this 
study were approved by the Institutional Review Board of 
Kyungpook National University Hospital (KNUH-74005-745) 
and informed consent was obtained from donors. 
After extraction, the teeth were placed and rinsed in biopsy 
media (Dulbecco’s modified Eagle’s medium [DMEM; Gibco 
BRL, Grand Island, NY, USA] with 500 U/mL penicillin and 
500 ug/mL streptomycin). After rinsing, only the PDL attached 
to the middle third of the root was removed with a curette to 
avoid contamination with the gingival and apical tissues. The 
PDL tissues were cut into small pieces and placed in small 
culture dishes. The tissues were incubated in biopsy medium 
at 37°C, 5% CO2, and 95% humidity. The medium was re-
placed with culture medium (DMEM with 10% fetal bovine 
serum [FBS], 100 U/mL penicillin and 100 µg/mL streptomy-
cin). After reaching confluence, the cells were passaged with 
0.25% trypsin/0.1% ethylene diaminotetraacetic acid. Two 
patients’ PDL cells between the fifth and sixth passage were 
used in the following studies. 
Mineralization nodule formation
PDL cells were plated at a density of 1×10
6 cells/100 mm in 
a Type I collagen coated petri dish and incubated in DMEM 
supplemented with 10% FBS, 100 U/mL penicillin, and 100 
µg/mL streptomycin. Cells were grown until confluent which 
was designated as day 0, and nodule formation was induced 
by the addition of 50 µg/mL ascorbic acid, 10 mM 
β-glyceropho  sphate (β-GP), and 100 nM dexamethasone to Journal of Periodontal
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the medium. The medium was changed every 3 days for 21 
days. The dishes were stained with Alizarin Red S to identify 
mineralization nodules on day 1, 7, 14, and 21. The medium 
was removed and the cells were washed with PBS and fixed 
in 2% paraformaldehyde for 30 minutes at 4°C. The cells 
were then gently washed with H2O. The cells were stained in 
a solution of 1% Alizarin Red S at pH 4.2 for 10 minutes at 
room temperature and were then washed with H2O, twice. 
The samples were air dried and were examined and photo-
graphed under a light microscope. To determine mineraliza-
tion, a percentage of the calcified areas of the total area per 
dish were analyzed using the image analysis program, I-so-
lution (IM Technology Inc., Daegeon, Korea). 
Real-time polymerase chain reaction (PCR) 
Total RNA extraction 
PDL cells were plated at a density of 1×10
6 cells/100 mm in 
a COL I coated petri dish and incubated in DMEM supple-
mented with 10% FBS, 100 U/mL penicillin, and 100 µg/mL 
streptomycin. Cells were grown until confluent which was 
designated as day 0, and mineralization was induced by the 
addition of 50 µg/mL ascorbic acid, 10 mM β-GP, and 100 
nM dexamethasone to the medium. Media was changed ev-
ery 3 days for 21 days. 
Total RNA was extracted from the cultured cells by using a 
modified acid phenol method on days 0, 1, 7, 14, and 21. Brief-
ly, the growth medium was removed and the cells were lysed 
with Trizol (Invitrogen, Carlsbad, CA, USA). The lysate was 
cleared and extracted with 1/10 the volume of 1-bromo-3-
chloporopane. The aqueous layer was collected in a new tube 
and precipitated with isopropanol. After 75% ethanol wash-
ing, the pellet was air-dried and resuspended in diethyl pyro-
carbonate-treated water, and quantified by A260/A280 mea-
surements using a UV spectrometer (DU530, Beckman Coul-
ter, Brea, CA, USA). 
Real-time PCR 
Total RNA was reverse-transcribed to produce cDNA using 
the ImProm-II reverse transcription system (Promega Inc., 
Madison, WI, USA) according to the manufacturer’s protocol. 
SYRB Green I-based real-time PCR was done on an MJ Re-
search DNA Engine Opticon Monitor II continuous fluores-
cence detection system (MJ Research Inc., Walthan, MA, USA). 
All PCR mixtures contained the following: PCR buffer [final 
concentration 10 mM Tris-Hcl (pH 9.0), 50 mM KCL, 2 mM 
MgCl2, and 0.1% Triton X-100), 250 mM deoxy-NTP (Roche, 
Mannheim, Germany), 0.5 mM of each PCR primer, 0.5X 
SYBR Green I (Invitrogen), 5% dimethyl sulfoxide, and 1 U 
taq DNA polymerase (Promega Inc.)] with 2 µL cDNA in a 25 
µL final volume reaction mix. The samples were loaded into 
the wells of Low Profile 96-well microplates. After an initial 
denaturation step for 1 minute at 94°C, the conditions for cy-
cling were as follows: 35 cycles of 30 second at 94°C, 30 sec-
ond at 53°C, and 1 minute at 72°C. The fluorescence signal 
was measured immediately after incubation for 5 seconds at 
78°C following the extension step, which eliminated possible 
primer dimer detection. At the end of the final PCR cycle, a 
melting curve was generated to identify the specificity of the 
PCR product. For each run, serial dilutions of human glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) plasmids 
were used as standards for the quantitative measurement for 
the amount of amplified DNA. All samples were run in dupli-
cates and the data were presented as a ratio of gene (c-myc, c-
fos, ALP, OC, BMP-2, and BMP-4) to GAPDH. The sequences 
of the primers used for the real-time PCR analysis are pre-
sented in Table 1. The primers used for the real-time PCR 
analysis were purchased from Bioneer Corporation (Dae-
geon, Korea). 
Statistical analysis
One-way analysis of variance was performed to determine 
the differences within and between groups with Tukey’s test 
as a post hoc test between day 0 and each day. A P-value of 
0.05 or less was considered to be statistically significant. 
RESULTS
Nodule formation during PDL cell differentiation
The culture dishes were stained with Alizarin Red S on days 
1, 7, 14, and 21. The PDL cells were incubated in mineralized 
medium over the course of 21 days. On days 1 and 7, no min-
eralization nodule was observed, but 5% and 33% of the cul-
ture dish had calcified by days 14 and 21, respectively (Fig. 1B). 
Table 1.  Primers and probes used in real-time polymerase chain re-
action.
Gene Sequence
C-myc F: 5‘- GGCCCCCAAGGTAGTTATCCTT -3’
R: 5‘- CGTTTCCGCAACAAGTCCTCT -3’
C-fos F: 5‘- AGACGGAGCCCTTTGATGACTT -3’
R: 5‘- TGCTGCATAGAAGGACCCAGAT -3’
ALP F: 5‘- CTGCCATCCTGTATGGCAATG -3’
R: 5‘- AGACTGCGCCTGGTAGTTGTTG -3’
BMP-2 F: 5‘- TTTGGACACCAGGTTGGTGAA -3’
R: 5‘- ACGAATCCATGGTTGGCGT -3’
BMP-4 F: 5‘- ATGAAGCCCCCAGCAGAAGT -3’
R: 5‘- TCACATTGTGGTGGACCAGTCT -3’
OC F: 5‘- TAGTGAAGAGACCCAGGCGCTA -3’
R: 5‘- TCACAGTCCGGATTGAGCTCA -3’
F: forward, R: reverse.Journal of Periodontal
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In the development of mineralized nodules by PDL cells, dis-
tinct stages were identified based on the appearance of the 
cultures. The first stage was the formation of the confluent 
monolayer of cells. These cells exhibited spindle or polygonal 
morphology (Fig. 1A-a). When treated with dexamethasone, 
ascorbic acid, and β-GP, cell proliferation began to occur in 
certain areas with the formation of several cell layers appear-
ing like clusters of cells. This is referred to as the multilayer 
formation stage (Fig. 1A-b). The next stage was associated 
with the formation of nodules formed by the deposition of 
the matrix in the clusters of cells and the initiation of nodule 
mineralization (Fig. 1A-c). In this stage, a few small mineral-
ized nodules started to develop on day 14. During the last 
stage, referred to as the post-mineralization stage, mineral-
ization of the matrix developed and the mineralization nod-
ule size also increased (Fig. 1A-d). 
Expression of mRNA for bone-related proteins during PDL 
cell differentiation
To determine the expression of bone-related proteins dur-
ing PDL cell differentiation, the expression level of their 
mRNAs was observed. c-myc is a cell growth-regulated gene 
and encodes proteins that support proliferation by function-
ing as transactivation factors. c-myc, as a proliferation mark-
er, showed maximal expression for the confluent cell stage 
(on day 0), then decreased by 25% of the maximal level on 
day 1. Thereafter, the c-myc mRNA expression level slightly 
increased to 60% of the maximal level and was maintained 
at that level (Fig. 2A). And there was a statistically significant 
difference as compared to day 0 and each day (P<0.05, Fig. 3).
As proliferation was downregulated, ALP mRNA was highly 
expressed. ALP mRNA showed a maximal expression level 
on day 7, and then declined to 32% and 12% of the maximal 
level on day 14 and 21, respectively (Fig. 2C). ALP is one of the 
earliest markers of osteoblastic cell differentiation. Thus, the 
active expression of the ALP gene on day 7 (multilayer forma-
tion stage) shows the initiation of PDL cell differentiation. 
On day 7 and 14, there was a statistically significant difference 
as compared with day 0 (P<0.05, Fig. 3).
BMPs belong to the TGF-β superfamily and have a variety 
of functions dependent upon tissue location and develop-
mental stage. Many studies have reinforced these findings 
demonstrating that BMPs promote the regeneration of bone 
and also periodontal tissues including alveolar bone, cemen-
tum, and PDL [13,14]. It has been reported that both gingival 
and PDL fibroblasts express mRNA for BMP-2 and -4 [15]. 
Therefore, the expressions of BMP-2 and -4 were observed to 
determine their expression patterns during PDL cell differ-
entiation. BMP-2 and -4 showed similar expression patterns 
to ALP. In the early stage (on days 0 and 1), the expression of 
BMP-2 was no more than 6% of the maximal level, but showed 
highly active expression on day 7, and, BMP-2 expression was 
followed by a decrease to 12% of the maximal level observed 
over the observational period (Fig. 2D). Similarly, expression 
of BMP-4 was 18% and 15% of the maximal level on days 0 
and 1, respectively and showed a maximal level on day 7. The 
expression of BMP-4 then decreased to about 20% of the 
maximal level seen on days 14 and 21 (Fig. 2E). On day 7, there 
was a statistically significant difference as compared with day 
0 (P<0.05, Fig. 3).
The active expression of ALP was followed by the active ex-
pression of OC. OC, as a marker for the mineralization stage, 
was expressed on day 7 (20% of the maximal level) and showed 
the maximal level on day 14. OC gene expression on day 21 
declined to 4% of the maximal level (Fig. 2F). The increase in 
OC gene expression on day 14 correlates with the formation 
of bone nodules. On day 14, there was a statistically signifi-
Figure 1.  Morphology of the various stages and percentage of cal-
cified areas during the formation of mineralized nodule by human 
periodontal ligament (PDL) cells.  (A) shows the visual field at ×200 
magnification on days 1(a), 7(b), 14(c), and 21(d). Developed mineral-
ization is observed and size and number of nodules are increased 
compared to PDL cells on day 14. (B) Measurement of calcified areas 
by Alizarin Red S stain. Data are shown as the mean±SD of two pa-
tients. Percentages of the calcified areas are 5% and 33% of the cul-
ture dish on day 14 and 21, respectively.
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1 7 14 21
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cant difference as compared with day 0 (P<0.05, Fig. 3).
 Like c-myc, c-fos is a cell growth regulated gene [16], and it 
has been reported that the expression of c-fos appears to pre-
cede terminal differentiation and cell death [17] and differen-
tiation of the osteoblast [18]. On day 0, for the active prolifer-
ation period, c-fos mRNA was expressed at 32% and declined 
to 18% of the maximal level. Then, c-fos expression levels 
gradually increased until day 21 when it showed the maximal 
level (P<0.05, Figs. 2B, 3). 
Other PDL cells were shown to have a similar gene expres-
sion pattern with each other. 
DISCUSSION
PDL cells in vivo have the capacity to differentiate into os-
teoblasts or cementoblasts, and to form alveolar bone and 
cementum, respectively. PDL cells in vitro have also been 
Figure 3.  Gene expression pattern during mineralization of peri-
odontal ligament cells. Expression of genes was analyzed by real-
time PCR and normalized to the levels of GAPDH mRNA. Values are 
presented as the percent of the maximal expression for each tran-
script. 
a)c-myc, 
b)c-fos, 
c)ALP, 
d)BMP-2, 
e)BMP-4, 
f)OC. 
a),c)-f)Statistically 
significant difference as compared with day 0 (P<0.05). 
b)(P>0/05).
Figure 2.  c-myc (A), c-fos (B), ALP (C), BMP-2 (D), BMP-4 (E), and OC (F) mRNA expression during mineralization of human periodontal liga-
ment (PDL) cells. The expression of each gene in PDL1 (a) and PDL2 (b) is shown. The graphs show the ratio of mRNA to GAPDH mRNA 
from the real-time polymerase chain reaction results. Control means the minimal gene expression level during 21 days. Values are 
means±SD of two cultures. 
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shown to possess osteoblast-like properties, including high 
constitutive levels of ALP activity, the production of cAMP in 
response to parathyroid hormones, and mineralized nodule 
formation. It was reported that mineralized nodules were 
formed in vitro by PDL cells [6-8]. 
The data obtained in this study indicate that the expression 
patterns of bone-related proteins, which are regulated in a 
temporal manner during successive developmental stages 
including proliferation, bone matrix formation/maturation, 
and mineralization, are unique in the PDL cell culture system 
as compared to other systems. 
The presence of the active proliferation stage is evidence 
for the temporal expression of bone-related proteins during 
PDL cell differentiation. Its presence has been supported by 
two observations. First, the lack of expression of OC and the 
formation of bone nodules support the presence of the pro-
liferation stage, and this is consistent with other systems such 
as those of rat calvarial osteoblasts [8] and bone marrow de-
rived osteoblasts [19]. Second, we found that the expression 
of c-myc gradually decreased during periodontal cell differ-
entiation. The downregulation of c-myc genes during cellular 
differentiation is similar to other studies done in a variety of 
cell types [8,20]. c-myc is a cell growth-regulated gene and en-
codes a protein that supports proliferation by functioning as 
a transactivation factor. It was reported that more than 95% 
of the cells proliferate after plating in normal rat diploid os-
teoblast cultures on day 5, and in that study, the cells showed 
the maximal expression of the c-myc gene [8]. In the present 
study, on day 0, for the active proliferation period showing 
the confluent cell stage, c-myc expression showed a maximal 
level, but the next day, decreased to 25% of the maximal level. 
It is suspected that the mineralization medium, added since 
day 0, has negative effects on periodontal cell proliferation. 
There is a transition point early in the developmental se-
quence that occurs when proliferation ceases and expression 
of genes related to the differentiated phenotype of osteoblasts 
is initiated. To determine the post-proliferation period, we 
observed ALP mRNA expression. ALP is one of the earliest 
markers for osteoblastic cells. Mineralization of the matrix is 
initiated by the expression of the membrane-bound glyco-
protein ALP. ALP is expressed in large amounts in osteoblasts 
in vivo and has also been found in differentiation studies 
with osteoblast-like cell lines in vitro [8,20,21]. We observed 
the maximal expression of ALP on day 7 for the multilayer 
formation stage prior to the initiation of nodule mineraliza-
tion. These results correspond to those of Stein and Lian [8] 
that ALP expression was maximal for the postproliferative 
period (on day 16) and decreased during the heavly mineral-
ization stage. 
BMPs belong to the TGF-β superfamily and have a variety 
of functions dependent on tissue location and developmen-
tal stage. In vitro studies using recombinant BMPs have dem-
onstrated that BMP-2, -4, -6, and -7 are potent inducers of os-
teoblast differentiation [22,23]. In vivo studies have reinforced 
these findings demonstrating that BMPs promote regenera-
tion of the bone and also periodontal tissues including bone, 
cementum, and PDL [13,14]. Strayhorn et al. [11] reported that 
BMPs decreased cell proliferation and promoted gene ex-
pression of BSP, OPN, and OC in MC3T3-E1 cell cultures. 
BMP-2, involved in the epithelial-mesenchymal interaction, 
plays an important role in cell differentiation [24], stimulates 
osteoblast differentiation, and bone formation [25]. We ob-
served that BMP-2 and -4 had similar expression patterns to 
ALP with gene expression maximal on day 7 and then declin-
ing until day 21. Previous studies have shown that BMP-2 
stimulates ALP activity and inhibits the induction of OC by 
1,25-dihydroxyvitamin D3 in hPDL cell cultures [26,27]. These 
results correspond with our observations related to BMP-2 
and OC. BMP-2 was highly expressed prior to OC expression, 
and OC was highly expressed when the expression of BMP-2 
declined to 22% of the maximal level. Also, BMP-2 enhanced 
BMP-4 mRNA expression in cultures of fetal rat calvarial os-
teoblasts [28]. BMP-4 stimulates OPN, Cbfa1, and BMP-2 ex-
pression in hPDL cells [29]. Thus, the enhancement of BMP-
2 by BMP-4 or BMP-4 by BMP-2 may be associated with the 
regulation of bone-related protein expression. However, in 
another study, BMP-4 mRNA was expressed when the ex-
pression of the extracellular matrix proteins was increased 
and BMP-2 mRNA was expressed when OC appeared during 
pulp cell differentiation into pre-odontoblasts [30].
The next evidence to support the existence of these stages 
during PDL cell differentiation was the formation of the 
nodules and expression of the OC gene. We call this period 
the mineralization stage. The nodule formation began to be 
observed on day 14 of this culture system and OC expression 
showed a maximal level on the same day. This result confirms 
the separate observations of the studies of MC3T3-E1 [9,31] 
and several other cells [8,32]. OC expression is well correlated 
to the time of mineralization of the nodules, and this supports 
the other studies that reported the major role of OC in min-
eralization. OC has been shown to contribute to the regula-
tion of the mineral phase in bone both in vitro as a potential 
inhibitor of mineral nucleation [33], and in vivo as a bone ma-
trix signal that promotes osteoclast differentiation and acti-
vation [34]. Thus, expression late in the osteoblast develop-
ment sequence suggests that OC is a marker of mature os-
teoblasts, which is consistent with a possible role for the syn-
thesis and binding of OC to minerals in the coupling of bone 
formation for resorption. Also, OC binds to COL I reversibly 
[35], and OPN and OC also form complexes in vitro [36]. How-Journal of Periodontal
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ever, we observed a decrease in OC expression up to 4% of 
the maximal level on day 21 showing advanced mineraliza-
tion. This finding is discordant with the results of studies in 
rat calvarial osteoblasts, bone marrow cells, MC3T3-E1 cells, 
and PDL cells [9,10,37,38]. They reported that OC expression 
was maintained once the mineralization of nodules was ini-
tiated. We assumed that the decreased expression level of 
OC on day 21 was related to apoptosis during PDL cell differ-
entiation. 
Apoptosis during osteogenesis has not been extensively 
studied, but it must play an important role in normal bone 
formation and remodeling. Apoptosis becomes a prominent 
feature of the in vitro culture in the late mineralization stage 
during the development of the mature osteoblast phenotype. 
The absence of ascorbic acid from the media to prevent nod-
ule formation and the absence of β-GP during the culture 
period to inhibit extracellular matrix (ECM) mineralization 
inhibit apoptosis. Conversely, the acceleration of differentia-
tion by dexamethasone leads to an increase in the number of 
apoptotic cells. Lynch et al. [21] reported the occurrence of 
cell death by apoptosis on day 29 when advanced mineraliza-
tion developed using a fetal rat calvaria-derived osteoblast 
culture. Shin et al. [39] observed that Dkk-1 and Nip3, which 
are apoptosis-inducing agents, were up-regulated, and Btf 
and TAX1BP1, which have an anti-apoptosis effect, were down-
regulated on day 21 when the nodules of the mineralized 
matrix were strongly stained with Alizarin Red S in the PDL 
cells cultured in the media with mineralization supplements. 
Thus, we call this period showing the advanced mineraliza-
tion and decreased OC expression level the post-mineraliza-
tion stage or cell death period. 
In relation to the decrease of OC expression on day 21, c-fos 
expression was maximal during the post-mineralization stage. 
Expression of c-fos appears to precede terminal differentia-
tion and cell death [17] and also precedes differentiation of 
osteoblasts [18]. Smeyne et al. [40] suggested three possible 
scenarios regarding the functional role of Fos in the process 
of cell death. First, expression may have no causal relation-
ship to cell death, but it may merely be a reflection of a break-
down of intracellular signal transduction. Second, the signal-
ing pathway that leads to cell death may result in a coinciden-
tal induction of c-fos and perhaps other immediate-early 
genes. Third, in some circumstances, the c-fos product may 
be a required component of the gene regulation pathway 
that leads to cell death. 
In conclusion, our results demonstrate that the expression 
patterns of bone-related proteins are regulated in a temporal 
manner during the successive developmental stages includ-
ing proliferation, bone matrix formation/maturation, and 
mineralization just like the rat calvarial osteoblast system [8]. 
However, the temporal expression patterns of some bone-
related proteins are unique in this culture system compared 
with other systems. Furthermore, on the basis of our results, 
we might be able to understand the various factors that in-
fluence PDL cell proliferation, extracellular matrix matura-
tion, and mineralization with regard to the gene expression 
patterns. 
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